Ad hoc: Carl Zeiss Meditec AG: Change in Management Board
(Thomson Reuters ONE) - Carl Zeiss Meditec AG / Board of directors / Ad hoc: Change in Management Board Ad hoc announcement according to §15 WpHG processed and transmitted by Hugin. The issuer is solely responsible for the content of this announcement. ------------------------------------------------------------------------------------JENA - November 12, 2009.After today's supervisory board meeting which ended at 2.44 pm, CarlZeiss Meditec AG (ISIN: DE0005313704) announces that in agreementwith the Supervisory and Management Boards its board member BerndHirsch will resign from the Management Board effective November 30,2009. Mr Hirsch is responsible for Finance and Controlling, InvestorRelations, Legal and Taxes, as well as Business Process Excellence.He is leaving the company on his own accord to take up a newchallenge outside the Carl Zeiss Group.The Supervisory Board thanks Mr Hirsch for his dedicated andsuccessful work in the Executive Board of Carl Zeiss Meditec.The company will be announcing details of his successor in the nearfuture.In the interim his duties will be taken over temporarily by boardmembers Dr. Michael Kaschke, Dr. Ludwin Monz and Ulrich Krauss.In the financial year 2008/2009 the company exceeded the givenforecast. Carl Zeiss Meditec will be publishing its annual financialstatements on December 14, 2009.Press contacts:Eva SesselmannCorporate CommunicationsCarl Zeiss Meditec AG07745 Jena, GermanyPhone: +49 3641 220-331Fax: +49 3641 220-112E-mail: press(at)meditec.zeiss.comPatrick KoflerInvestor RelationsCarl Zeiss Meditec AG07745 Jena, GermanyPhone: +49 3641 220-106Fax: +49 3641 220-117E-mail: investors(at)meditec.zeiss.comBrief profileCarl Zeiss Meditec AG (ISIN: DE 0005313704) is one of the world'sleading medical technology companies. The company supplies innovativetechnologies and application-oriented solutions designed to helpdoctors improve the quality of life of their patients. It providescomplete packages of solutions for the diagnosis and treatment of eyediseases - including implants and consumable materials. The companycreates innovative visualisation solutions in the field ofmicrosurgery. Carl Zeiss Meditec's medical technology portfolio isrounded off by promising future technologies such as intraoperativeradiation therapy.In the 2007/2008 (30 September) financial year the 2,100 employeesgenerated sales of about ? 600 million. The head office of Carl ZeissMeditec is in Jena, Germany. The company has subsidiaries in Germanyand abroad; more than 50 percent of its employees are based in theUSA, Japan, Spain and France.35 percent of Carl Zeiss Meditec shares are in free float. Theremaining 65 percent are held by Carl Zeiss AG, one of the world'sleading groups in the optical and opto-electronics industry. The fiveindependently managed business units of Carl Zeiss AG operate in thefuture-oriented markets of "Medical and Research Solutions","Industrial Solutions" and "Lifestyle Products". The head office ofCarl Zeiss AG is in Oberkochen, Germany. In the 2007/08 financialyear (balance sheet date 30 September) the group posted sales of? 2.7 billion. Carl Zeiss has a total workforce of about 13,000 inover 30 countries, over 8,000 of them in Germany.Further information: www.meditec.zeiss.com --- End of Message ---Carl Zeiss Meditec AGGoeschwitzer Strasse 51-52 Jena GermanyWKN: 531370; ISIN: DE0005313704; Index: Prime All Share, TECH All Share, TecDAX;Listed: Freiverkehr in Bayerische Börse München, Freiverkehr in Börse Stuttgart, Freiverkehr in Börse Berlin, Freiverkehr in Börse Düsseldorf, Freiverkehr in Hanseatische Wertpapierbörse zu Hamburg, Freiverkehr in Niedersächsische Börse zu Hannover, Prime Standard in Frankfurter Wertpapierbörse, Regulierter Markt in Frankfurter Wertpapierbörse;
Datum: 12.11.2009 - 15:27 Uhr
Sprache: Deutsch
News-ID 8311
Anzahl Zeichen: 0
contact information:
Town:
London
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 275 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ad hoc: Carl Zeiss Meditec AG: Change in Management Board"
steht unter der journalistisch-redaktionellen Verantwortung von
Carl Zeiss Meditec AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
